| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c152cf0c2bd684e03aad6629dd5e02f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-54 |
| filingDate |
2020-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8c058abc092ca59aa675d429de0a7c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07dc30f16108ea91083206a9955c034d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc1bb99c808f6ec14da46033ac54ff9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de3ff85a4caa1e98e18284c88aa866a5 |
| publicationDate |
2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022112152-A1 |
| titleOfInvention |
Triphenylphosphonium-tethered salicylamine derivatives |
| abstract |
Novel salicylamine derivatives are targeted directly to the mitochondria to increase effectiveness and lower required dosages in the treatment of conditions caused by inflammation or oxidative stress. |
| priorityDate |
2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |